Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Toronto Stock Exchange  >  Cardiome Pharma Corp    COM   CA14159U3010

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Toronto Stock Exchange
07/18/2016 07/19/2016 07/20/2016 07/21/2016 07/22/2016 Date
6.98 6.87 6.87 7.02 7.1 Last
5100 1810 5000 4227 1431 Volume
+1.75% -1.58% 0.00% +2.18% +1.14% Change
Financials ( CAD)
Sales 2016 35,7 M
EBIT 2016 -17,9 M
Net income 2016 -19,8 M
Debt 2016 -
Yield 2016 -
Sales 2017 46,2 M
EBIT 2017 -4,85 M
Net income 2017 -11,8 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales2016 4,06x
Capi. / Sales2017 3,14x
Capitalization 145 M
More Financials
Company
Cardiome Pharma Corp. is a specialty pharmaceutical company.It engages in the discovery, development and commercialization of cardiovascular therapies that will improve the health of patients suffering from heart disease.Cardiome has two marketed products, BRINAVESS, approved in Europe and other... 
Sector
Pharmaceuticals
Calendar
08/08Earnings Release
More about the company
Surperformance© ratings of Cardiome Pharma Corp
Trading Rating : Investor Rating :
More Ratings
Latest news on CARDIOME PHARMA CORP
07/18 CARDIOME PHARMA : Veritas Provides Investor Update
07/14 CARDIOME PHARMA : ESMOCARD® and ESMOCARD LYO® receive pricing approval and reimb..
06/28 CARDIOME PHARMA : Announces Voting Results
06/24 CARDIOME PHARMA CORP. : Announces Voting Results
06/14 CARDIOME PHARMA : Announces Term Loan Agreement with CRG-Managed Funds
05/13 CARDIOME PHARMA : Reports First Quarter 2016 Financial Results
05/12 CARDIOME PHARMA : Announces the Launch of ESMOCARD Solution for Injection in Fra..
05/11 CARDIOME PHARMA : Announces Publication of Spanish Emergency Department BRINAVES..
05/11 CARDIOME PHARMA : to Hold First Quarter 2016 Financial Results Conference Call o..
05/06 IIROC Trade Resumption - Cardiome Pharma Corp.
More news
Sector news : Biopharmaceuticals
07/22DJJOHNSON & JOHNSON : Acclarent Unit in $18 Million U.S. Settlement
07/22DJJOHNSON & JOHNSON : Acclarent Unit in $18 Million U.S. Settlement
07/22DJBAYER : 2Q 2016 -- Forecast
07/22DJMonsanto Wins EU Nod for New Biotech Soybeans
07/21DJBIOGEN : Announces CEO Search, Lifts Guidance--2nd Update
More sector news : Biopharmaceuticals
News from SeekingAlpha
06/03 Healthcare ratings roundup - new coverage
05/13 Cardiome Pharma's (CRME) CEO Bill Hunter on Q1 2016 Results - Earnings Call T..
05/13 Cardiome Pharma revenues up 29%; net loss improves by 74% in Q1
05/13 Cardiome Pharma beats by $0.15, beats on revenue
05/12 Notable earnings before Friday?s open
Advertisement
Chart CARDIOME PHARMA CORP
Duration : Period :
Cardiome Pharma Corp Technical Analysis Chart | COM | CA14159U3010 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Average target price 14,0  CAD
Spread / Average Target 97%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
William L. Hunter President, Chief Executive Officer & Director
William James O'Shea Chairman
Sheila M. Grant Chief Operating Officer
Jennifer Archibald Chief Financial Officer
Harold H. Shlevin Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CARDIOME PHARMA CORP-32.77%110
CSL LIMITED13.10%40 749
ALEXION PHARMACEUTICAL..-34.05%28 182
GRIFOLS SA-6.03%13 901
JIANGXI BOYA BIO-PHARM..--.--%2 638
3SBIO INC-26.30%2 594
More Results